Global Newcastle Disease Vaccine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Newcastle Disease Vaccine market size will reach 374.12 Million USD in 2025 and is projected to reach 484.09 Million USD by 2032, with a CAGR of 3.75% (2025-2032). Notably, the China Newcastle Disease Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Newcastle Disease Vaccine is a type of vaccine used to protect poultry, particularly chickens, against Newcastle disease (ND), also known as avian paramyxovirus type 1. Newcastle disease is a highly contagious viral infection that affects birds, causing respiratory, nervous system, and gastrointestinal symptoms. The vaccine is developed using live or inactivated strains of Newcastle disease virus and is administered to chickens via various routes, such as drinking water, spray, or eye drops. The vaccine stimulates the bird’s immune system to produce antibodies against the virus, providing protection and reducing the severity of the disease if the bird is exposed to the ND virus in the future. Newcastle Disease Vaccine plays a crucial role in preventing Newcastle disease outbreaks, ensuring the health and productivity of poultry flocks, and safeguarding the poultry industry.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, Zoetis, DHN, Elanco (Lohmann), ChengDu Tecbond, FATRO, CAVAC, Vaksindo, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Newcastle Disease Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Newcastle Disease Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Newcastle Disease Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Newcastle Disease Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Newcastle Disease Vaccine Include:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
DHN
Elanco (Lohmann)
ChengDu Tecbond
FATRO
CAVAC
Vaksindo
Newcastle Disease Vaccine Product Segment Include:
Live Vaccines
Killed Vaccines
Newcastle Disease Vaccine Product Application Include:
Chicken
Duck & Goose
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Newcastle Disease Vaccine Industry PESTEL Analysis
Chapter 3: Global Newcastle Disease Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Newcastle Disease Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Newcastle Disease Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Newcastle Disease Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Newcastle Disease Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Newcastle Disease Vaccine market size will reach 374.12 Million USD in 2025 and is projected to reach 484.09 Million USD by 2032, with a CAGR of 3.75% (2025-2032). Notably, the China Newcastle Disease Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Newcastle Disease Vaccine is a type of vaccine used to protect poultry, particularly chickens, against Newcastle disease (ND), also known as avian paramyxovirus type 1. Newcastle disease is a highly contagious viral infection that affects birds, causing respiratory, nervous system, and gastrointestinal symptoms. The vaccine is developed using live or inactivated strains of Newcastle disease virus and is administered to chickens via various routes, such as drinking water, spray, or eye drops. The vaccine stimulates the bird’s immune system to produce antibodies against the virus, providing protection and reducing the severity of the disease if the bird is exposed to the ND virus in the future. Newcastle Disease Vaccine plays a crucial role in preventing Newcastle disease outbreaks, ensuring the health and productivity of poultry flocks, and safeguarding the poultry industry.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, Zoetis, DHN, Elanco (Lohmann), ChengDu Tecbond, FATRO, CAVAC, Vaksindo, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Newcastle Disease Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Newcastle Disease Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Newcastle Disease Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Newcastle Disease Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Newcastle Disease Vaccine Include:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
DHN
Elanco (Lohmann)
ChengDu Tecbond
FATRO
CAVAC
Vaksindo
Newcastle Disease Vaccine Product Segment Include:
Live Vaccines
Killed Vaccines
Newcastle Disease Vaccine Product Application Include:
Chicken
Duck & Goose
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Newcastle Disease Vaccine Industry PESTEL Analysis
Chapter 3: Global Newcastle Disease Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Newcastle Disease Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Newcastle Disease Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Newcastle Disease Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Newcastle Disease Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Newcastle Disease Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Newcastle Disease Vaccine Product by Type
- 1.2.1 Live Vaccines
- 1.2.2 Killed Vaccines
- 1.3 Newcastle Disease Vaccine Product by Application
- 1.3.1 Chicken
- 1.3.2 Duck & Goose
- 1.3.3 Other
- 1.4 Global Newcastle Disease Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Newcastle Disease Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Newcastle Disease Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Newcastle Disease Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Newcastle Disease Vaccine Market Development Status and Trends
- 1.5.1 Newcastle Disease Vaccine Industry Development Status Analysis
- 1.5.2 Newcastle Disease Vaccine Industry Development Trends Analysis
- 2 Newcastle Disease Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Newcastle Disease Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Newcastle Disease Vaccine Market Analysis by Country
- 4.1 Global Newcastle Disease Vaccine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Newcastle Disease Vaccine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Newcastle Disease Vaccine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Newcastle Disease Vaccine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Newcastle Disease Vaccine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Newcastle Disease Vaccine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Newcastle Disease Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Newcastle Disease Vaccine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Newcastle Disease Vaccine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Newcastle Disease Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Newcastle Disease Vaccine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Newcastle Disease Vaccine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Newcastle Disease Vaccine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Newcastle Disease Vaccine Market Analysis by Type
- 6.1 Global Newcastle Disease Vaccine Market Revenue Analysis by Type
- 6.1.1 Global Newcastle Disease Vaccine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Newcastle Disease Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Newcastle Disease Vaccine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Newcastle Disease Vaccine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Merial
- 7.1.1 Merial Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Merial Newcastle Disease Vaccine Product Portfolio
- 7.1.3 Merial Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 CEVA
- 7.2.1 CEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CEVA Newcastle Disease Vaccine Product Portfolio
- 7.2.3 CEVA Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 QYH Biotech
- 7.3.1 QYH Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 QYH Biotech Newcastle Disease Vaccine Product Portfolio
- 7.3.3 QYH Biotech Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Ringpu Biology
- 7.4.1 Ringpu Biology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
- 7.4.3 Ringpu Biology Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Yebio
- 7.5.1 Yebio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Yebio Newcastle Disease Vaccine Product Portfolio
- 7.5.3 Yebio Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Harbin Veterinary Research Institute
- 7.6.1 Harbin Veterinary Research Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
- 7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Merck Animal Health
- 7.7.1 Merck Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
- 7.7.3 Merck Animal Health Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Zoetis
- 7.8.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Zoetis Newcastle Disease Vaccine Product Portfolio
- 7.8.3 Zoetis Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 DHN
- 7.9.1 DHN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 DHN Newcastle Disease Vaccine Product Portfolio
- 7.9.3 DHN Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Elanco (Lohmann)
- 7.10.1 Elanco (Lohmann) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
- 7.10.3 Elanco (Lohmann) Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 ChengDu Tecbond
- 7.11.1 ChengDu Tecbond Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
- 7.11.3 ChengDu Tecbond Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 FATRO
- 7.12.1 FATRO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 FATRO Newcastle Disease Vaccine Product Portfolio
- 7.12.3 FATRO Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 CAVAC
- 7.13.1 CAVAC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 CAVAC Newcastle Disease Vaccine Product Portfolio
- 7.13.3 CAVAC Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 Vaksindo
- 7.14.1 Vaksindo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Vaksindo Newcastle Disease Vaccine Product Portfolio
- 7.14.3 Vaksindo Newcastle Disease Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Newcastle Disease Vaccine Industry Chain Analysis
- 8.2 Newcastle Disease Vaccine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Newcastle Disease Vaccine Product Downstream Application Analysis
- 8.3.1 Global Newcastle Disease Vaccine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Newcastle Disease Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Newcastle Disease Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Newcastle Disease Vaccine Typical Downstream Customers
- 8.5 Newcastle Disease Vaccine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
